Published in J Clin Sleep Med on February 15, 2009
Obstructive sleep apnea in poorly controlled asthmatic children: effect of adenotonsillectomy. Pediatr Pulmonol (2011) 1.72
Respiratory symptoms, sleep-disordered breathing and biomarkers in nocturnal gastroesophageal reflux. Respir Res (2016) 1.38
Association between asthma and risk of developing obstructive sleep apnea. JAMA (2015) 1.26
Association of obstructive sleep apnea risk or diagnosis with daytime asthma in adults. J Asthma (2012) 0.92
Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity. J Asthma (2011) 0.88
Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma. J Asthma (2014) 0.84
Effects of inhaled fluticasone on upper airway during sleep and wakefulness in asthma: a pilot study. J Clin Sleep Med (2014) 0.84
Body mass index and comorbidities in adult severe asthmatics. Biomed Res Int (2014) 0.83
Chronic cough and OSA: a new association? J Clin Sleep Med (2011) 0.80
Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study. Diabetes Res Clin Pract (2012) 0.79
Obstructive sleep apnea and asthma. J Bras Pneumol (2013) 0.79
Asthma and Obstructive Sleep Apnea. Chin Med J (Engl) (2015) 0.78
Oximetry Signal Processing Identifies REM Sleep-Related Vulnerability Trait in Asthmatic Children. Sleep Disord (2013) 0.77
Association of Obstructive Sleep Apnea with Asthma: A Meta-Analysis. Sci Rep (2017) 0.75
Fragile X and Obstructive Sleep Apnea Syndrome: Case Presentation and Management Challenges. J Clin Sleep Med (2016) 0.75
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases. J Thorac Dis (2016) 0.75
Associations Between Excessive Daytime Sleepiness and Functional Gastrointestinal Disorders: A Population-based Study in China. J Neurogastroenterol Motil (2016) 0.75
Asthma and Subjective Sleep Disordered Breathing in a Large Cohort of Urban Adolescents. J Asthma (2016) 0.75
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 16.98
Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med (1999) 12.71
Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (1992) 10.10
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet (1981) 9.07
Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep (2005) 6.64
Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med (1999) 6.21
Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med (2002) 5.15
Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl) (1999) 4.85
Bronchial hyperreactivity. Am Rev Respir Dis (1980) 4.77
Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77
Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol (2004) 4.72
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab (1997) 4.47
Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med (2002) 4.35
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34
Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology (2003) 4.28
Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med (1999) 3.89
Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax (1991) 3.77
Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest (1997) 3.51
Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med (2002) 3.16
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest (2002) 3.05
Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J (2005) 3.05
Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation (2003) 2.98
Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation (1992) 2.88
Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest (2002) 2.86
Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation (2003) 2.71
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med (2000) 2.55
Prevalence of symptoms and risk of sleep apnea in the US population: Results from the national sleep foundation sleep in America 2005 poll. Chest (2006) 2.55
Endothelins. N Engl J Med (1995) 2.52
Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med (1997) 2.48
The effects of ventilation of dogs with different gas mixtures on airway calibre and lung mechanics. J Physiol (1966) 2.42
Symptomatic gastroesophageal reflux in subjects with a breathing sleep disorder. Chest (2002) 2.40
Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest (2004) 2.35
Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am J Respir Crit Care Med (2004) 2.20
Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy. Am Rev Respir Dis (1991) 2.12
Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol (2001) 2.12
Effect of changes in blood gas tensions and carotid sinus pressure on tracheal volume and total lung resistance to airflow. J Physiol (1962) 2.09
Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med (2002) 2.08
Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol (2005) 2.08
Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet (1984) 2.04
Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med (2000) 1.97
Gastroesophageal reflux and asthma: a possible reflex mechanism. Ann Allergy (1978) 1.95
Reflex effects of upper airway irritation on total lung resistance and blood pressure. J Appl Physiol (1962) 1.93
The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy (2002) 1.90
Responses to ozone are increased in obese mice. J Appl Physiol (1985) (2003) 1.79
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest (1996) 1.76
Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med (2004) 1.75
Surgical removal of the carotid body for bronchial asthma. Dis Chest (1961) 1.73
Marked improvement in nocturnal gastroesophageal reflux in a large cohort of patients with obstructive sleep apnea treated with continuous positive airway pressure. Arch Intern Med (2003) 1.72
Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72
Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol (2003) 1.62
Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea--hypopnea syndrome. Blood (2001) 1.58
Parasympathetic nervous system in nocturnal asthma. Br Med J (Clin Res Ed) (1988) 1.57
Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol (2000) 1.56
Obstructive sleep apnea and gastroesophageal reflux. Am J Med (2000) 1.55
Bronchial hyperresponsiveness to inhaled methacholine in subjects with chronic left heart failure at a time of exacerbation and after increasing diuretic therapy. Chest (1989) 1.52
Sleep apnoea syndrome: states of sleep and autonomic dysfunction. J Neurol Neurosurg Psychiatry (1977) 1.51
Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med (1989) 1.50
The role of the vague nerve in airway narrowing caused by intraesophageal hydrochloric acid provocation and esophageal distention. Ann Allergy (1981) 1.46
Influence of sleep on lung volume in asthmatic patients and normal subjects. J Appl Physiol (1985) (1990) 1.45
Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol (1985) (1995) 1.44
Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax (1995) 1.42
Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med (2004) 1.41
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J (2003) 1.41
Leptin: does it have any role in childhood asthma? J Allergy Clin Immunol (2004) 1.40
Nasal CPAP reduces gastroesophageal reflux in obstructive sleep apnea syndrome. Chest (1992) 1.38
Body mass index and asthma in adults in families of subjects with asthma in Anqing, China. Am J Respir Crit Care Med (2001) 1.36
Relation of bronchial responsiveness to body mass index in the ECRHS. European Community Respiratory Health Survey. Thorax (2002) 1.34
Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med (1996) 1.33
Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology (1984) 1.32
Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax (2002) 1.30
Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J (2006) 1.29
Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax (2000) 1.27
Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J (1996) 1.25
Inflammation in the uvula mucosa of patients with obstructive sleep apnea. Laryngoscope (1996) 1.25
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy (2003) 1.24
Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest (1986) 1.23
Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis (1988) 1.23
Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol (2002) 1.22
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.22
Leptin: a multifunctional hormone. Cell Res (2000) 1.21
Histopathologic changes in snoring and obstructive sleep apnea syndrome. Laryngoscope (1991) 1.20
TNF-[alpha] modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl. J Appl Physiol (1985) (2003) 1.16
Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol (1985) (1999) 1.15
Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest (2007) 1.14
Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest (1997) 1.14
Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects. Am J Respir Crit Care Med (1994) 1.14
Nasal continuous positive airway pressure. A new treatment for nocturnal gastroesophageal reflux? J Clin Gastroenterol (1993) 1.13
Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax (1993) 1.12
Body mass index and asthma severity among adults presenting to the emergency department. Chest (2003) 1.11
Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy (2000) 1.11
Pulmonary aspiration as a consequence of gastroesophageal reflux: a diagnostic approach. Dig Dis Sci (1979) 1.11
The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. Ann Allergy (1982) 1.10
Breathing route during sleep. Am Rev Respir Dis (1986) 1.10
Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer. J Biol Chem (1998) 1.10
Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest (2005) 1.09
Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med (2001) 1.08
Difficult-to-control asthma and obstructive sleep apnea. J Asthma (2003) 1.07
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment. Ann Allergy Asthma Immunol (2008) 0.91